Skip to content
SHPHShuttle Pharmaceuticals Holdings, Inc.

Earnings

When Shuttle Pharmaceuticals Holdings, Inc. reports, what it reported each quarter, and how the stock took the results.

22 quarters. Mar 31, 2021 to Jun 30, 2026. mixed units.

Next results · Q3 2026Running late

Tuesday, after the close

Tue, Nov 24, 2026in 6 days

Its usual day, Nov 17, 2026, passed with no release on file.

Quarter
Q3 2026 · Ended Sep 30, 2026
10-Q window
Nov 9 – Dec 8

Read against Q3 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
—
Net income
-$2.35M
Net income, change from a year earlier: Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m, Q3 2025 n/m
EPS
-$1.05
EPS, change from a year earlier: Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m, Q2 2025 n/m

Quarter by quarter

Q2 2026-$3.15MNo Q2 2025 on file

Latest results

  1. Q2 2026Sep 24, 2026, during market hours+6.4%by the close of Sep 24
    Revenue
    —
    —
    Net income
    -$3.15M
    N/M
    EPS
    -$3.10
    N/M
  2. Q1 2026May 15, 2026, after the close7.8%by the close of May 18
    Revenue
    —
    —
    Net income
    -$2.15M
    N/M
    EPS
    -$0.43
    N/M
  3. Q4 2025Feb 17, 2026, after the closeThe release+7.4%by the close of Feb 19
    Revenue
    —
    —
    Net income
    -$2.61M
    N/M
    EPS
    —
    —
  4. Q3 2025Nov 13, 2025, during market hours8.0%by the close of Nov 13
    Revenue
    —
    —
    Net income
    -$2.35M
    N/M
    EPS
    -$1.05
    N/M

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q2 2026Jun 30, 2026—Sep 24, 202686 d10-Q——-$3.10+6.4%
Q1 2026Mar 31, 2026—May 15, 202645 d10-Q——-$0.437.8%
FY 2025
Q4 2025derivedDec 31, 2025Feb 17, 2026 · after-hoursMar 31, 202690 d10-K———+7.4%
Q3 2025Sep 30, 2025—Nov 13, 202544 d10-Q——-$1.058.0%
Q2 2025Jun 30, 2025—Aug 13, 202544 d10-Q——-$32.912.5%
Q1 2025Mar 31, 2025—May 8, 202538 d10-Q——-$7.6014.8%
FY 2024
Q4 2024derivedDec 31, 2024Feb 26, 2025 · market hoursFeb 26, 202557 d10-K———+2.7%
Q3 2024Sep 30, 2024Nov 13, 2024 · after-hoursNov 13, 202444 d10-Q——-$39.830.9%
Q2 2024Jun 30, 2024—Sep 4, 202466 d10-Q——-$24.12+12.9%
Q1 2024Mar 31, 2024—May 13, 202443 d10-Q——-$0.83+2.4%
Earlier years, FY 2021 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QSep 24, 2026044107
10-QMay 15, 2026023859
10-KMar 31, 2026014131
10-QNov 13, 2025022162
10-QAug 13, 2025023263
10-QMay 8, 2025009325
10-KFeb 26, 2025008300
10-QNov 13, 2024045176
10-QSep 4, 2024034902
10-QMay 13, 2024018944

Provenance

ProvenanceData status and checks

Shuttle Pharmaceuticals Holdings, Inc. · CIK 1757499 · Engraved from SEC EDGAR